Literature DB >> 19233575

A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.

Sílvia C Barros1, Benedita Cruz, Tiago M Luís, Fernanda Ramos, Teresa Fagulha, Margarida Duarte, Margarida Henriques, Miguel Fevereiro.   

Abstract

Vaccination programs for the control of bluetongue (BT) in ruminants have limitations due to difficulties in differentiating infected from vaccinated animals (DIVA). To overcome this problem a DIVA test that looks at a differential immune response to bluetongue virus (BTV) non-structural protein 3 (NS3) was developed. The NS3 encoding gene of strain BTV4/22045/PT04 was inserted into expression vector pET-28a and expressed in Escherichia coli strain JM109. Recombinant NS3 protein was used as an antigen in an indirect ELISA (NS3-ELISA) to measure the serologic response to NS3 protein in cattle and sheep. Following a cattle vaccination/challenge experiment with a bivalent inactivated BTV 2-4 vaccine, NS3 antibodies were detected at approximately 15 days post-infection in control unvaccinated animal, while vaccinated animals did not develop detectable NS3 antibodies and, with exception of one, remained negative even after virus challenge. The inactivated vaccine induced antibodies against the major core structural protein (VP7) of BTV as well as neutralizing antibodies in all animals. To evaluate the applicability of NS3-ELISA in field scenario, a total of 562 serum samples collected from uninfected, BTV-infected and vaccinated animals were tested for NS3 antibodies. Taken together, the results confirm that NS3 antibodies were induced to the greatest levels in animals infected with BTV in comparison to the levels induced in animals immunized with inactivated BTV vaccines, implying that antibody response to NS3 allows the differentiation between infected and vaccinated animals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233575     DOI: 10.1016/j.vetmic.2009.01.033

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  9 in total

1.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1.

Authors:  Jung-Yong Yeh; Kyung Min Chung; Jaewhan Song
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

3.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

4.  Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.

Authors:  Jenna Anderson; Sara Hägglund; Emmanuel Bréard; Loic Comtet; Karin Lövgren Bengtsson; John Pringle; Stéphan Zientara; Jean Francois Valarcher
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

5.  Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock.

Authors:  David J Paton; Geraldine Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

6.  An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model.

Authors:  Guanggang Ma; Michael Eschbaumer; Abdelrahman Said; Bernd Hoffmann; Martin Beer; Nikolaus Osterrieder
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

Review 7.  Diagnosing bluetongue virus in domestic ruminants: current perspectives.

Authors:  José M Rojas; Daniel Rodríguez-Martín; Verónica Martín; Noemí Sevilla
Journal:  Vet Med (Auckl)       Date:  2019-02-14

8.  Bluetongue in India: a systematic review and meta-analysis with emphasis on diagnosis and seroprevalence.

Authors:  Ramkumar N Rupner; O R VinodhKumar; R Karthikeyan; D K Sinha; K P Singh; Z B Dubal; Shikha Tamta; V K Gupta; B R Singh; Y S Malik; K Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

9.  The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.

Authors:  Piet A van Rijn; Mieke A Maris-Veldhuis; René G P van Gennip
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.